Living in Boulder, Colorado one can’t help but be an RNA fan. What with the Nobel Prize winning work of Tom Cech (who I plan to next highlight in my Colorado Entrepreneur Profiles) for the discovery of catalytic properties of RNA, to the work being done at Sirna where RNAi technology is being used to [...]

• 56http://clsdf.com/2006/02/boulder-co-an-rna-state-of-mind/Boulder%2C+CO%3A+An+RNA+State+of+Mind2006-02-02+15%3A44%3A00admin

Array BioPharma Inc. (Nasdaq: ARRY) and AstraZeneca PLC selected an additional clinical candidate for their small molecule anti-cancer program, triggering a $1 million milestone payment from AstraZeneca to Array. In December 2003, Array partnered the oncology portion of its MEK program, including its lead compound, ARRY-142886 (AZD6244), for co-development and commercialization with AstraZeneca. At that [...]

• 55http://clsdf.com/2006/02/lots-of-good-news-from-array/Lots+of+Good+News+From+Array2006-02-01+16%3A12%3A00admin

The University of Colorado Technology Transfer Office has two immediate openings for Temporary Licensing Associates. The position is responsible for assisting in the management and administration of a portfolio of intellectual property. This includes assessing technical merit, patentability and commercial feasibility of campus inventions. This also includes working with inventor-generated contacts and using research resources [...]

• 54http://clsdf.com/2006/02/life-science-licensing-associate-position/Life+Science+Licensing+Associate+Position2006-02-01+15%3A53%3A00admin